Table 1.
Baseline characteristics of the population.
| Age (years; mean ± SD, range) | 62.3 ± 2.3 (60–65) |
| Smoking habits (yes; n., %) | 2/7 (28.6%) |
| Family history of DM (n., %) | 7/7 (100%) |
| Diabetes duration (years; mean ± SD, range) | 8.4 ± 2.2 (4–12) |
| Total Cholesterol (mg/dl; mean ± SD, range) | 152.6 ± 32.7 (124.0–203.0) |
| Triglycerides (mg/dl; mean ± SD, range) | 114.0 ± 26.0 (84.0–143.0) |
| HDL Cholesterol (mg/dL; mean ± SD, range) | 46.8 ± 16.4 (33.0–70.0) |
| Total Testosterone (ng/mL; mean ± SD, range) | 2.1 ± 0.4 (1.7–2.5) |
| LH (mIU/mL; mean ± SD, range) | 5.9 ± 4.7 (2.0–15.9) |
| FSH (mIU/mL; mean ± SD, range) | 11.9 ± 10.6 (2.6–31.3) |
| Prolactin (ng/mL; mean ± SD, range) | 4.5 ± 1.2 (3.8–5.5) |
| Total PSA (ng/mL; mean ± SD, range) | 1.1 ± 0.7 (0.3–2.1) |
| SHBG (nmol/L; mean ± SD, range) | 28.7 ± 8.3 8 (19.1–33.7) |
| Hematocrit (%; mean ± SD, range) | 44.2 ± 2.9 (40.2–49.0) |
| Hb (ng/dL; mean ± SD, range) | 15.1 ± 1.1 (13.6–16.7) |
| BMI (kg/m2; mean ± SD, range) | 29.9 ± 2.4 (26.4–32.8) |
LH: luteinizing hormone; FSH: Follicle-stimulating hormone; SHBG: sex hormone binding globulin; PSA: prostate-specific antigen; Hb: hemoglobin.